BASF has launched three plant protection products in Brazil, including bromoflufenamide and propiconazole, with commercialization expected within 2 to 3 years.

Published Feb 4, 2026

Tridge summary

Core tip: As reported by the World Agrochemicals Network Chinese website, BASF recently released its nematode-resistant soybean (NRS) trait in Brazil, positioning it as a biotechnology that promises to transform Brazilian agriculture. The company estimates that this innovation could bring an incremental value of 15 billion to 20 billion Brazilian reals (approximately $3 billion to $4 billion) to the Brazilian soybean production sector. BASF executives compared its economic impact to that of the first-generation glyphosate-resistant (Roundup Ready) technology introduced over two decades ago.

Original content

At the "crop tours" event in Mato Grosso, BASF simultaneously showcased its NRS trait and two other new crop protection molecules. All three technologies are planned for commercialization within the next two to three years, currently awaiting final approval from relevant regulatory authorities. GMB151 transformant: A combination of nematode resistance and herbicide tolerance The NRS trait is integrated into the genetically modified soybean GMB151, which was obtained through Agrobacterium tumefaciens-mediated transformation technology. The vector pSZ8832 used contains two expression cassettes, cry14Ab-1.b and hppdPf-4Pa, which respectively express the Cry14Ab-1 protein and the modified 4-hydroxyphenylpyruvate dioxygenase (HPPD-4) protein. The Cry14Ab-1 protein, derived from Bacillus thuringiensis, confers resistance to plant parasitic nematodes in soybeans; the HPPD-4 protein, derived from Pseudomonas fluorescens, provides tolerance to HPPD inhibitor class herbicides. The ...
Source: Foodmate

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.